Subscribe to RSS Feed
Medicines-Diabetes Treatment-Alkoy-DoctorN-LomaLux-Gedeon Richter-Renewal-NovoNordisk-Ursapharm-Merck Sharp & Dohme-LeoLab-Rompharm-Elfa-ALKALOID-BelMed-EGIS-Innotech-AlfaWassermann-Vifor-Nanjing-Lek-Bristol-Myers Squibb-Adipharm-Alcon-Simpex-Farmak-Medana-Zhengzhou Pharmaceutical
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Alkoy-DoctorN-LomaLux-Gedeon Richter-Renewal-NovoNordisk-Ursapharm-Merck Sharp & Dohme-LeoLab-Rompharm-Elfa-ALKALOID-BelMed-EGIS-Innotech-AlfaWassermann-Vifor-Nanjing-Lek-Bristol-Myers Squibb-Adipharm-Alcon-Simpex-Farmak-Medana-Zhengzhou Pharmaceutical
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Alkoy
DoctorN
LomaLux
Gedeon Richter
Renewal
NovoNordisk
Ursapharm
Merck Sharp & Dohme
LeoLab
Rompharm
Elfa
ALKALOID
BelMed
EGIS
Innotech
AlfaWassermann
Vifor
Nanjing
Lek
Bristol-Myers Squibb
Adipharm
Alcon
Simpex
Farmak
Medana
Zhengzhou Pharmaceutical
- The purpose of the medication
- Manufacturer
